Sign in: Staff/Students
The University of Liverpool’s Professor Sir Munir Pirmohamed has been appointed by the Secretary of State for Health and Social Care as Chair of the Commission on Human Medicines (CHM).
The CHM provides independent expert advice to ministers on the safety, quality and efficacy of medicines. It is an advisory non-departmental public body, sponsored by the Department of Health and Social Care.
Health Minister Lord Bethell said: “I am pleased to confirm Professor Sir Munir Pirmohamed as Chair of the Commission on Human Medicines (CHM).
“He provides a wealth of clinical experience and expertise in pharmacology, genetics and the safety of medicines. He will lead the CHM at a time when its role and profile continues to be critically important in its independent and scientific assessments of the safety, quality and efficacy of COVID-19 vaccines, as well as all other vaccines and medicines, to protect public health.”
Professor Sir Munir Pirmohamed, David Weatherall Chair of Medicine at the University of Liverpool said: “I am delighted to be appointed Chair of the CHM. The Commission is widely respected internationally for its work in licensing new medicines and monitoring their safety. Patient and public safety remains at the forefront of our work and I will make sure that the vital role we play in ensuring the medicines we take continue to meet the highest standards of safety, quality and efficacy.”
Professor Sir Munir Pirmohamed is a clinical pharmacologist and geneticist who currently holds the David Weatherall Chair in Medicine at the University of Liverpool and is a Consultant Physician at Liverpool University Hospitals NHS Foundation Trust. Sir Munir holds the only NHS Chair of Pharmacogenetics in the UK, is Director of the Medical Research Council Centre for Drug Safety Sciences and Director of the Wolfson Centre for Personalised Medicine. He is a Fellow of the Academy of Medical Sciences and was until recently a CHM Commissioner and Vice Chair.
Professor Sir Munir Pirmohamed has been appointed as Chair of the Commission on Human Medicines for 4 years from 12 February 2021. He will also continue in his role as chair of the CHM’s COVID-19 Vaccines Benefit Risk Expert Working Group.
Click here for more information on the Commission for Human Medicines.
All recent news
Lateral flow tests detect most people at risk of transmitting Covid-19
Free digital skills training for Liverpool students
Social disadvantage in the UK has a lasting impact on childhood asthma
Win a year’s tuition fees with Santander Universities UK
How to share your feedback with us – Student Feedback Hub
Professor Eithne Costello from @LivUni on the link between Type 2 Diabetes and Pancreatic Cancer #ITVTonight at 8pm.
Professor Chris Holloran of The University Of Liverpool (@LivUni) explains the importance of diagnosing Pancreatic Cancer early.
You can watch the full episode on #ITVTonight at 8pm
Researchers from @LivCancerRes feature in a new @ITVTonight film about #PancreaticCancer.
Profs Chris Halloran & Eithne Costello discuss the importance of early detection & the research taking place to help to improve outcomes.
📺 Watch 'Britain's Hidden Killer' on ITV at 8pm.